Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02526706 · ClinicalTrials.gov registry record · NA
Using a Type of Blue Dye to Observe Bleb Function During Cataract Surgery
A NA study, sponsored by Wills Eye.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT02526706 is a NA study that has completed, run by Wills Eye. The registered enrollment target is 15 participants.
The verdict
NCT02526706, a NA study, has completed, sponsored by Wills Eye.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
The investigators aim to conduct a prospective clinical pilot study to investigate the use of VisionBlue staining administered during cataract surgery to 20 patients with history of trabeculectomy for glaucoma as a means to assess functioning of an existing filtering bleb. The investigators also aim to develop a standard classification system for assessing filtering bleb function during cataract surgery.
Interventions
- OTHER VisionBlue
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2015-08 |
| Est. Completion | 2016-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02526706
The ClinicalTrials.gov registry entry for NCT02526706 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wills Eye, which has 59 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which VisionBlue is the first listed.
NCT02526706 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02526706 about?
NCT02526706 is a clinical study titled "Using a Type of Blue Dye to Observe Bleb Function During Cataract Surgery". The investigators aim to conduct a prospective clinical pilot study to investigate the use of VisionBlue staining administered during cataract surgery to 20 patients with history of trabeculectomy for glaucoma as a means to assess functioning of an existing filtering bleb. The investigators also aim...
What is the current status of trial NCT02526706?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2015-08. Estimated completion is 2016-10.
What interventions are being tested in trial NCT02526706?
The interventions under investigation include: VisionBlue (OTHER).
Who is sponsoring clinical trial NCT02526706?
This trial is sponsored by Wills Eye, which has 59 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.